Amerise Biosciences Ltd Stock Price Today (NSE: AMERISE)
Fundamental Score
Amerise Biosciences Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Amerise Biosciences Ltd share price today is ₹0.71, up +4.41% on NSE/BSE as of 19 June 2026. Amerise Biosciences Ltd (AMERISE) is a Small-cap company in the Plastic Products - Industrial sector with a market capitalisation of ₹3.97 (Cr). The 52-week high for AMERISE share price is ₹0.92 and the 52-week low is ₹0.50. At a P/E ratio of 99.19x, AMERISE is currently trading above its industry average P/E of 23.37x. The company has a Return on Equity (ROE) of 0.19% and a debt-to-equity ratio of 0.00.
Amerise Biosciences Ltd Share Price Chart — NSE/BSE Historical Performance
Amerise Biosciences Ltd share price chart: -1.39% return over the past month. 52-week high ₹0.92, 52-week low ₹0.50.
Amerise Biosciences Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹0.67 | ₹0.71 | ₹0.67 | ₹0.71 | 50.84K (Cr) | |
| ₹0.71 | ₹0.71 | ₹0.68 | ₹0.68 | 15.53K (Cr) | |
| ₹0.69 | ₹0.71 | ₹0.69 | ₹0.71 | 9.81K (Cr) | |
| ₹0.71 | ₹0.71 | ₹0.71 | ₹0.71 | 40.95K (Cr) | |
| ₹0.71 | ₹0.71 | ₹0.71 | ₹0.71 | 21.79K (Cr) | |
| ₹0.69 | ₹0.71 | ₹0.69 | ₹0.71 | 12.68K (Cr) | |
| ₹0.71 | ₹0.71 | ₹0.68 | ₹0.68 | 2.11L (Cr) | |
| ₹0.74 | ₹0.74 | ₹0.71 | ₹0.71 | 9.66K (Cr) | |
| ₹0.74 | ₹0.74 | ₹0.74 | ₹0.74 | 7.68K (Cr) | |
| ₹0.71 | ₹0.74 | ₹0.71 | ₹0.74 | 11.84K (Cr) |
Amerise Biosciences Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹0.71 | ₹0.71 | ₹0.67 | ₹0.71 | +0.00% | |
| ₹0.70 | ₹0.80 | ₹0.68 | ₹0.71 | +1.43% | |
| ₹0.59 | ₹0.78 | ₹0.59 | ₹0.69 | +16.95% | |
| ₹0.69 | ₹0.72 | ₹0.50 | ₹0.59 | -14.49% | |
| ₹0.61 | ₹0.84 | ₹0.60 | ₹0.70 | +14.75% | |
| ₹0.61 | ₹0.70 | ₹0.53 | ₹0.61 | +0.00% | |
| ₹0.62 | ₹0.70 | ₹0.51 | ₹0.61 | -1.61% | |
| ₹0.63 | ₹0.73 | ₹0.55 | ₹0.62 | -1.59% | |
| ₹0.65 | ₹0.71 | ₹0.55 | ₹0.63 | -3.08% | |
| ₹0.78 | ₹0.78 | ₹0.65 | ₹0.65 | -16.67% | |
| ₹0.70 | ₹0.79 | ₹0.69 | ₹0.69 | -1.43% | |
| ₹0.85 | ₹0.92 | ₹0.67 | ₹0.70 | -17.65% |
AI Research Briefing
Powered by Gemini · 2026-04-09
This is a zero-revenue zombie stock trading on hope; avoid at all costs.
WHAT'S HAPPENING NOW (last 2-4 weeks)
No major catalysts found after live search. The The market is likely pricing in hope of a turnaround or acquisition, despite zero revenue.
WHAT IS DRIVING THE STOCK
Micro-cap speculation: Low price attracts retail investors hoping for a quick buck.
'Recovery Setup Building' narrative: Despite no fundamental change, old articles suggest some are betting on a turnaround.
- Micro-cap speculation
- 'Recovery Setup Building' narrative
- Low stock price
- Reverse merger
- Acquisition
- Sudden influx of working capital
- Zero revenue
- No operations
- Micro/SME cap - liquidity risk
- Questionable management
- No promoter holding
No FII or DII interest. Promoter holding is zero. Smart money is staying far away.
The Indian plastic industry is projected to grow, but Amerise isn't participating.
Free Cash Flow 5Y: ₹2.44 Cr. But with no revenue, this is irrelevant.
Zero. Unless a miracle occurs, this company is going nowhere. Any positive movement will be short-lived and based on speculation, not fundamentals.
Primary Thesis Risk
Complete collapse of the company due to lack of operations and revenue.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Amerise Biosciences Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Amerise Biosciences Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of AMERISE across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Excellent EPS Growth (15.63% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (15.63% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
6 factors identified
Below-Average Return on Equity (0.19%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (0.19%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Premium Valuation Risk (P/E: 99.19x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Profit Decline Concern (-33.33%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Low Promoter Commitment (0.00%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Amerise Biosciences Ltd vs Plastic Products - Industrial Peers
Peer Comparison - Plastic Products - Industrial
Compare Amerise Biosciences Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Amerise Biosciences LtdAmerise Bioscie...Selected✓ AMERISE • 531681 | 9.2/100 | ₹0.71₹1 | ₹3.97₹3.97 | 99.19Average 99.2 Average | 0.19%Poor 0.19% Poor | 0.19%Poor 0.19% Poor | 0.00Excellent 0.0 Excellent | 15.63%Excellent 15.63% Excellent | — — | 0.00% |
Supreme Industries LtdSupreme Industr... SUPREMEIND • 509930 | 53.6/100 | ₹3520.70₹3521 | ₹42365.85₹42365.85 | 49.96Average 50.0 Average | 17.14%Good 17.14% Good | 22.04%Excellent 22.04% Excellent | 0.06Excellent 0.1 Excellent | 14.56%Good 14.56% Good | 13.64%Good 13.64% Good | 1.02% |
Astral LimitedAstral Limited... ASTRAL • 532830 | 61.1/100 | ₹1533.10₹1533 | ₹38732.66₹38732.66 | 76.05Average 76.0 Average | 14.89%Average 14.89% Average | 19.71%Good 19.71% Good | 0.07Excellent 0.1 Excellent | 15.44%Excellent 15.44% Excellent | 17.74%Excellent 17.74% Excellent | 0.26% |
Shaily Engineering Plastics LtdShaily Engineer... SHAILY • 501423 | 43.6/100 | ₹3144.80₹3145 | ₹12031.71₹12031.71 | 82.32Average 82.3 Average | 18.49%Good 18.49% Good | 19.52%Good 19.52% Good | 0.30Excellent 0.3 Excellent | — — | — — | 0.08% |
Finolex Industries LtdFinolex Industr... FINPIPE • 500940 | 46.3/100 | ₹177.97₹178 | ₹10944.52₹10944.52 | 25.02Average 25.0 Average | 6.76%Poor 6.76% Poor | 8.77%Poor 8.77% Poor | 0.00Excellent 0.0 Excellent | 4.12%Average 4.12% Average | 6.77%Good 6.77% Good | 1.13% |
Time Technoplast LtdTime Technoplas... TIMETECHNO • 532856 | 52.7/100 | ₹171.92₹172 | ₹9836.32₹9836.32 | 23.37Average 23.4 Average | 14.22%Average 14.22% Average | 17.35%Good 17.35% Good | 0.22Excellent 0.2 Excellent | 18.02%Excellent 18.02% Excellent | 8.81%Good 8.81% Good | 0.63% |
Garware Hi Tech Films LtdGarware Hi Tech... GRWRHITECH • 500655 | 58.1/100 | ₹5813.50₹5814 | ₹8989.88₹8989.88 | 28.73Average 28.7 Average | 15.00%Good 15.00% Good | 20.57%Excellent 20.57% Excellent | 0.01Excellent 0.0 Excellent | 31.28%Excellent 31.28% Excellent | 17.93%Excellent 17.93% Excellent | 0.31% |
Kingfa Science & Technology Co, LtdKingfa Science ... KINGFA • 524019 | 60.3/100 | ₹5296.00₹5296 | ₹5906.41₹5906.41 | 37.51Average 37.5 Average | 23.21%Excellent 23.21% Excellent | 30.55%Excellent 30.55% Excellent | 0.01Excellent 0.0 Excellent | 44.08%Excellent 44.08% Excellent | 18.66%Excellent 18.66% Excellent | 0.00% |
Prince Pipes & Fittings LtdPrince Pipes & ... PRINCEPIPE • 542907 | 17.1/100 | ₹257.55₹258 | ₹3009.44₹3009.44 | 129.66Average 129.7 Average | 2.73%Poor 2.73% Poor | 3.85%Poor 3.85% Poor | 0.15Excellent 0.1 Excellent | -17.77%Poor -17.77% Poor | 9.06%Good 9.06% Good | 0.18% |
Jai Corp LtdJai Corp Ltd... JAICORPLTD • 512237 | 53.4/100 | ₹113.85₹114 | ₹2510.08₹2510.08 | 15.02Average 15.0 Average | 4.10%Poor 4.10% Poor | 4.18%Poor 4.18% Poor | 0.00Excellent 0.0 Excellent | 15.29%Excellent 15.29% Excellent | -0.35%Poor -0.35% Poor | 0.35% |
R M DRIP & SPRINK SYS LTDR M DRIP & SPRI... RMDRIP • 544456 | 60.6/100 | ₹17.05₹17 | ₹1978.13₹1978.13 | 62.94Average 62.9 Average | 39.70%Excellent 39.70% Excellent | 44.66%Excellent 44.66% Excellent | 0.41Excellent 0.4 Excellent | 53.59%Excellent 53.59% Excellent | 41.18%Excellent 41.18% Excellent | 0.06% |
Top Plastic Products - Industrial Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Supreme Industries Ltd share price42365.85 Cr
- Astral Limited share price38732.66 Cr
- Shaily Engineering Plastics Ltd share price12031.71 Cr
- Finolex Industries Ltd share price10944.52 Cr
- Time Technoplast Ltd share price9836.32 Cr
Amerise Biosciences Ltd Quarterly Performance
Latest quarterly metrics for AMERISE — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
N/A
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-33.33%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
N/A
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
15.63%
Compounded annual net profit growth over 5 years
Amerise Biosciences Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for AMERISE — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Amerise Biosciences Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Amerise Biosciences Ltd (AMERISE) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Amerise Biosciences Ltd
About AMERISE (Amerise Biosciences Ltd)
Amerise Biosciences Ltd is a fledgling enterprise venturing into the specialized field of industrial plastic products, currently laying the groundwork for future operations. While ...the company is in its nascent stages, the vision is to establish a robust manufacturing and distribution network catering to diverse industrial needs. Amerise aims to specialize in high-performance plastics, engineered for durability, resilience, and adaptability across various demanding applications. The core focus will be on creating custom solutions for sectors requiring superior materials, emphasizing innovation in plastic compound development and molding processes. Though currently focused on building infrastructure and developing key partnerships, Amerise Biosciences anticipates significant growth and impact as it moves towards full-scale production. The foundation of Amerise Biosciences' future success rests on a commitment to research and development, aimed at producing cutting-edge plastic products. The company intends to invest heavily in advanced technologies, including specialized extrusion and injection molding equipment, and a dedicated team of engineers and material scientists. This strategic focus will allow for the creation of specialized plastic components for a wide range of sectors, including automotive, aerospace, and construction. By incorporating sustainable practices into its manufacturing processes, Amerise Biosciences also aims to minimize its environmental impact, utilizing recycled materials and implementing energy-efficient technologies, furthering a commitment to responsible industry growth and resource management. Established with a refreshed purpose and vision, Amerise Biosciences Ltd leverages its corporate history as a launchpad for a new chapter in industrial plastics. Transitioning from previous ventures, the company has undergone a strategic re-alignment to concentrate on the burgeoning market for specialized plastic products. Headquartered in Ahmedabad, India, Amerise is strategically positioned to access a vibrant and diverse industrial ecosystem, offering substantial advantages in manufacturing and logistics. With a clear focus on establishing strong relationships with both suppliers and customers, Amerise Biosciences is dedicated to building a lasting legacy in the plastics industry through a commitment to quality, innovation, and customer satisfaction.
Company Details
Key Leadership
Latest News
AMERISE Share Price: Frequently Asked Questions
What is the current share price of Amerise Biosciences Ltd?
Amerise Biosciences Ltd (AMERISE) trades at ₹0.71 on NSE and BSE. Market cap ₹3.97 (Cr). Educational data only.
What is the P/E ratio of Amerise Biosciences Ltd?
Amerise Biosciences Ltd has a P/E of 99.19x vs industry average 23.37x.
What is the Bull Run score for Amerise Biosciences Ltd?
Amerise Biosciences Ltd has a Bull Run score of 9.2/100 based on 25+ financial parameters.
Does Amerise Biosciences Ltd pay dividends?
Amerise Biosciences Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Amerise Biosciences Ltd?
Amerise Biosciences Ltd has ROE of 0.19%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Amerise Biosciences Ltd?
Amerise Biosciences Ltd has debt-to-equity of 0.00.
Is Amerise Biosciences Ltd a good investment?
Bull Run gives Amerise Biosciences Ltd a score of 9.2/100. This is not investment advice — consult a SEBI-registered advisor.